% | $
Quotes you view appear here for quick access.

Cadence Pharmaceuticals, AŞ Message Board

  • dragan7777777777 dragan7777777777 Dec 3, 2012 10:44 PM Flag

    OT: NAVB....

    You might want to keep an eye on this. NAVB has a few reasons to be considered:

    1. CRL on manufacturing only means almost "certain" FDA approval on resubmission ( but never say never )

    2. almost no competition

    3. CH partnership, huge backup on marketing, sales force, possibility for buyout

    4. they have pipelines ( dementia, Alzheimer )

    PDUFA date is April 30. A lots of time to get in.